沙利德胺对动脉样硬化的影响:肠道微生物群的潜在贡献
Si-Fan Fei1, Can Hou1, Fang Jia1
1Department of Cardiovascular Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Frontiers in pharmacology
|August 2, 2024
概括
沙利德胺通过调节肠道微生物群的组成和改善肠道屏障功能来预防动脉样硬化. 这种天然化合物还可以减少与肠道失调相关的炎症,提供一种新的治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 微生物组科学 微生物组科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化心血管疾病 (ASCVD) 与肠道微生物群的改变有关.
- 肠道微生物组组成和代谢物影响内皮功能障碍和动脉样硬化.
- 化是一种天然化合物,在管理ASCVD方面显示出潜力.
研究的目的:
- 审查salidroside对动脉样硬化进展的保护作用.
- 阐明沙利德化物与肠道微生物群相互作用的机制.
- 为了突出肠道微生物群在沙利德胺的有益作用中的作用.
主要方法:
- 文献综述侧重于ASCVD中的沙利德和肠道微生物群.
- 对调查沙利德胺对微生物组成和代谢物的影响的研究分析.
- 对沙利德胺对肠道屏障功能和炎症的影响的研究进行了审查.
主要成果:
- 沙利德化物调节肠道微生物群的丰富性和相关代谢物.
- 它改善了肠道屏障功能和上皮质完整性.
- 沙利化物减轻了因肠道微生物群干扰而加剧的炎症.
结论:
- 沙利德胺通过调节肠道微生物群来改善动脉样硬化.
- 它增强了肠道屏障功能,并减少了微生物群驱动的炎症.
- 肠道微生物群在salidroside对ASCVD的治疗作用中发挥着关键作用.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
What is Monogastric Digestion?
71.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.0K


